We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > pain drug

News List

More positive results for Pfizer/Lilly’s non-opioid pain drug pharmaphorum
February 22, 2019
Pfizer and Eli Lilly have announced more positive results from a phase 3 study of their non-opioid pain drug tanezumab, this time in chronic lower back pain (CBLP).
Lexicon pain drug advances after clearing early clinical test fiercebiotech
December 25, 2018
A phase 1a trial of Lexicon Pharmaceuticals’ LX9211 has met its primary objectives. The study found the AAK1 inhibitor was well tolerated, teeing Lexicon up to advance the neuropathic pain prospect.....
Pfizer again supplying pain drugs to veterinarians shunted aside because of hospital shortages fiercepharma
December 19, 2018
Pfizer shut off supplies of pain drugs to veterinarians when a shortage of an injected opioid meant it couldn’t fill all of the orders it had from hospitals. But relief is now on the way for vets and their animal patients, the FDA says.
US delay for AbbVie/Neurocrine’s uterine pain drug pharmatimes
April 13, 2018
The US Food and Drug Administration has extended its review of AbbVie and Neurocrine’s experimental uterine pain drug elagolix by three months.
Piramal buys Mallinckrodt’s pain drug portfolio financialexpress
March 21, 2017
Piramal’s critical care business is a global player in the hospital generics segment